Belgium’s largest pharma company, has announced findings from a collection of real-world evidence studies to reaffirm the ...

Company to share new preclinical combination data for FHD-909 (LY4050784), a potential first-in-class selective SMARCA2 inhibitor, with non-small cell lung cancer (NSCLC) as the primary target ...

A patisserie has partnered with a biotech startup to recycle cake waste to be used to tackle pollution in agriculture and ...

The collaboration aims to provide advanced resources and scientific expertise to accelerate innovation and drive sustainable ...

A family patisserie has teamed up with a biotech start-up company to recycle waste from cake-cutting into bacteria-based ...

But Youle’s dismissal, along with 10 others at the NIH’s National Institute of Neurological Disorders and Stroke, underscores ...

CHEYENNE, WY / ACCESS Newswire / April 15, 2025 / Neuss, Germany: CS Diagnostics Corp. is pleased to announce that it has received a Letter of Intent from SAN ART CAPITAL SAS, a leading advisory and ...

CHINO HILLS, CA / ACCESS Newswire / April 10, 2025 / SOHM, Inc. (OTC PINK:SHMN), a pharmaceutical and biotechnology company specializing in generic drugs and gene-editing tools, is thrilled to announc ...

She also presented the 180 the Concept Aesthetics Pioneer Awards, honoring contributors who’ve shaped the brand’s journey.

Relay Therapeutics gains capital via licensing, reduces costs, and advances its promising PI3K-alpha inhibitor. See why RLAY ...

The key event of the meeting was the signing of a Memorandum of Understanding (MoU) aimed at fostering deeper cooperation ...

JW Marriott Kaafu Atoll Island Resort announces its exclusive partnership with BABOR, the globally renowned German expert skincare ...